This inventor holds 2 USPTO granted patents. Top assignees: University of Bern, University of Washington. Active years: 2006-2009.
Company Filing History:
2 out of 26 
2 out of 2,166 
Years Active: 2006-2009
Title: Natalie Glavas: Innovator in Nucleic Acid Technologies
Introduction
Natalie Glavas is a prominent inventor based in Daly City, CA (US). She has made significant contributions to the field of nucleic acid technologies, holding 2 patents that showcase her innovative work. Her research focuses on the development of novel phosphodiesterase (PDE) proteins and their applications in medical diagnostics and treatments.
Latest Patents
One of her latest patents, titled "PDEs and uses thereof," provides isolated full-length nucleic acid molecules encoding the novel PDE protein. This invention includes methods for utilizing these nucleic acid molecules, which also encompass peptide nucleic acids (PNA) and antisense molecules. The patent further discusses agonists, antibodies, antagonists, or inhibitors of the activity of these novel PDE proteins. These compositions are valuable for diagnosing, preventing, or treating conditions associated with the presence or deficiency of novel PDE proteins.
Career Highlights
Throughout her career, Natalie has worked with esteemed institutions such as the University of Washington and the University of Bern. Her research has significantly advanced the understanding of PDE proteins and their potential therapeutic applications.
Collaborations
Natalie has collaborated with notable colleagues, including Joseph A. Beavo and Thomas Seebeck, who have contributed to her research endeavors and innovations in the field.
Conclusion
Natalie Glavas is a trailblazer in the realm of nucleic acid technologies, with her patents paving the way for advancements in medical science. Her work continues to inspire future innovations in the field.